Med-Eng Pleased to Support United States Department of War with Delivery of Sensor Capabilities Contract Previously Announced by Cadre Holdings

OGDENSBURG, NY — As originally announced by Cadre Holdings, Inc. (“Cadre”), on November 19, 2025, Med-Eng, LLC, a world leader in personal protective technologies against blast and a subsidiary of Cadre, was awarded a 5-year Indefinite Delivery / Indefinite Quantity (IDIQ) contract with a maximum value of $50 million by the United States Department of War (DoW) to deliver and support the Blast Exposure Monitoring (BEMO) Program. The BEMO systems, including sensor hardware and related software, measure and record blast overpressure exposures experienced in training operations as part of a DoW Brain Health program.

First delivery under the contract is underway and follows a competitive 5-year funded development program to improve methods for identifying blast overpressure exposures impacting the warfighter while using heavy weapon systems and conducting explosive breaching in dynamic combat and training environments. Once deployed, real-time updates will be available for team leaders, commanders, and medical personnel, enabling rapid triage decisions and dynamic adjustments to tactics, techniques, and procedures (TTPs).

Med-Eng General Manager Rob Reynolds commented, “I am extremely proud of the Med-Eng team for the tireless efforts they have shown throughout this multi-year program and since contract award in late 2025. At each phase of the open competition, the team showed its ability to listen, evolve and deliver. This is the latest demonstration of how Med-Eng can leverage its deep understanding of blast threats to develop new, technology-based solutions that will help the short and long term health of the warfighter. This capability will form a key part of monitoring the effects of blast overpressure exposures during training and will significantly increase the empirical data knowledge base of the military medical community. We look forward to supporting the customer through the delivery phases and to developing our sensor capabilities to meet evolving threats.”

Med-Eng has been a pioneer in the development and fielding of body-worn blast sensors since 2006. This latest generation is a significant step forward in the convergence of hardware, mobile device apps, and intuitive dashboards to bridge the gap between blast overpressure events and longitudinal brain health monitoring. This will help team leaders, medical staff, and senior leadership to utilize powerful decision-making tools based on tracking both single event and cumulative blast overpressure exposure.